ArticleFrontiers in immunology2024

A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer.

Lijuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.